Peer-reviewed veterinary case report
Home-based subcutaneous continuous glucose monitoring in 10 diabetic dogs.
- Journal:
- The Veterinary record
- Year:
- 2011
- Authors:
- Affenzeller, N et al.
- Affiliation:
- Clinic of Internal Medicine
- Species:
- dog
Plain-English summary
In a study involving ten diabetic dogs, researchers tested a new device that continuously monitors blood sugar levels at home. These dogs were stable and wore the monitoring system for up to 48 hours while their owners recorded details like feeding times and insulin doses. The device was successfully implanted without any issues, and the glucose data collected helped veterinarians make treatment adjustments for all the dogs. Notably, six of the dogs experienced low or high blood sugar episodes during the monitoring period. Overall, the study showed that this glucose monitoring system can be useful for managing diabetes in dogs.
Abstract
A subcutaneous continuous glucose monitoring system (GlucoDay; Menarini Diagnostics) based on microdialysis was investigated for its clinical applicability in veterinary medicine. Ten diabetic dogs, referred as clinically stable, were equipped with this system and sent home for a maximum observation period of 48 hours. Time of insulin administration, feeding and other events were written in a diary and plotted afterwards in the glucose graph. Implantation of the microdialysis fibre, acceptance of the device and evaluation of individual canine glucose profiles were without complication. Based on the monitoring data, recommended treatment adjustments were given to the referring veterinarians in all 10 dogs; hypoglycaemic or prolonged hyperglycaemic episodes were detected in six dogs.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/21795310/